Development of In Vitro Toxicology Assays using Human Pluripotent Stem Cells and Targeted Metabolomics (December 2018)
Dec 13, 2018 2:00 - 3:00 PM EST
Jessica A. Palmer, Stemina Biomarker Discovery, Inc.
Thorough QT-QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships (November 2018)
Presenter: Weihsueh A. Chiu, PhD, Texas A&M University
Stem Cell-Based in Vitro Models: State-of-the-Art Tools to Predict Drug-Induced Tissue Injury in Humans (October 2018)
Presenter: Prof. Joery De Kock, Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel
Adverse Outcome Pathways: An update on progress and some near-term applications (September 2018)
Kristie Sullivan (1) and Mathieu Vinken (2)
1 Physicians Committee for Responsible Medicine, Washington, DC
2 Department of In Vitro Toxicology and Dermato-Cosmetology, Vrije Universiteit Brussel, Belgium.
New Tools and Features in the Integrated Chemical Environment (ICE) (August 2018)
Shannon Bell, PhD
Computational Toxicologist, Integrated Laboratory Systems, Inc.
Microphysiological Systems: Innovative tools for drug development and disease modeling (March 2018)
Presenter: Lucie Low, PhD, National Center for Advancing Translational Sciences
Human Organs on Chips (July 2017)
Anthony Bahinski, PhD, MBA, FAHA
GlaxoSmithKline, King of Prussia, PA, United States
Combination of multiple neural crest migration assays to identify environmental toxicants from a proof‑of‑concept chemical library (June 2017)
Johanna Nyffeler, In Vitro Toxicology and Biomedicine, University of Konstanz, Germany
2016 Student Award Winners Webinar (January 2017)
Modeling a complex in vivo response in vitro: Exploring heterogeneity and mechanisms associated with ozone adaptation, Emma Bowers, University of North Carolina
Single-cell analysis reveals that silver nanoparticle exposure leads to multi-nucleation through defective cell division, Ellen Garcia, Virginia Tech